1. Author Reply To: Hepatitis B Reactivation in Chronic Hepatitis C Patients during Treatment with Ledipasvir and Sofosbuvir. Issue 3 (April 2018) Authors: Gane, Edward J; Hyland, Robert H; An, Di; Svarovskaia, Evguenia S; Brainard, Diana; McHutchison, John G Journal: Antiviral therapy Issue: Volume 23:Issue 3(2018) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Issue 6 (June 2019) Authors: Wohl, David A; Yazdanpanah, Yazdan; Baumgarten, Axel; Clarke, Amanda; Thompson, Melanie A; Brinson, Cynthia; Hagins, Debbie; Ramgopal, Moti N; Antinori, Andrea; Wei, Xuelian; Acosta, Rima; Collins, Sean E; Brainard, Diana; Martin, Hal Journal: Lancet Issue: Volume 6:Issue 6(2019) Page Start: e355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV. (1st December 2021) Authors: Orkin, Chloe; Ajana, Faiza; Kityo, Cissy; Koenig, Ellen; Natukunda, Eva; Gandhi-Patel, Bhumi; Wang, Hui; Liu, Yapei; Wei, Xuelian; White, Kirsten; Makadzange, Tariro; Pikora, Cheryl; McNicholl, Ian; Collins, Sean E.; Brainard, Diana; Chuck, Susan K. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 88:Number 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials. (1st December 2021) Authors: Orkin, Chloe; Ajana, Faiza; Kityo, Cissy; Koenig, Ellen; Natukunda, Eva; Gandhi-Patel, Bhumi; Wang, Hui; Liu, Yapei; Wei, Xuelian; White, Kirsten; Makadzange, Tariro; Pikora, Cheryl; McNicholl, Ian; Collins, Sean E.; Brainard, Diana; Chuck, Susan K. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 88:Number 4(2021) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials. (1st December 2021) Authors: Orkin, Chloe; Ajana, Faiza; Kityo, Cissy; Koenig, Ellen; Natukunda, Eva; Gandhi-Patel, Bhumi; Wang, Hui; Liu, Yapei; Wei, Xuelian; White, Kirsten; Makadzange, Tariro; Pikora, Cheryl; McNicholl, Ian; Collins, Sean E.; Brainard, Diana; Chuck, Susan K. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 88:Number 4(2021) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Issue 2 (15th December 2014) Authors: Hedskog, Charlotte; Doehle, Brian; Chodavarapu, Krishna; Gontcharova, Viktoria; Crespo Garcia, Javier; De Knegt, Robert; Drenth, Joost P.H; McHutchison, John G.; Brainard, Diana; Stamm, Luisa M.; Miller, Michael D.; Svarovskaia, Evguenia; Mo, Hongmei Journal: Hepatology Issue: Volume 61:Issue 2(2015:Feb.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Issue 6 (June 2019) Authors: Stellbrink, Hans-Jürgen; Arribas, José R; Stephens, Jeffrey L; Albrecht, Helmut; Sax, Paul E; Maggiolo, Franco; Creticos, Catherine; Martorell, Claudia T; Wei, Xuelian; Acosta, Rima; Collins, Sean E; Brainard, Diana; Martin, Hal Journal: Lancet Issue: Volume 6:Issue 6(2019) Page Start: e364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development of sofosbuvir for the treatment of hepatitis C virus infection. Issue 1 (31st July 2015) Authors: Lawitz, Eric; Jacobson, Ira M.; Nelson, David R.; Zeuzem, Stefan; Sulkowski, Mark S.; Esteban, Rafael; Brainard, Diana; McNally, John; Symonds, William T.; McHutchison, John G.; Dieterich, Douglas; Gane, Edward Journal: Annals of the New York Academy of Sciences Issue: Volume 1358:Issue 1(2015) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IDDF2019-ABS-0134 Sofosbuvir/velpatasvir is effective and safe in patients with concomitant proton pump inhibitor use in clinical studies. (June 2019) Authors: Esteban, Rafael; Agarwal, Kosh; Calleja, Jose Luis; Dufour, Jean-Francois; Flamm, Steven; Gordon, Stuart; Stamm, Luisa; Ni, Liyun; Brainard, Diana; Sze Man Yip, Christina; Kowdley, Kris; Cooper, Curtis; Pineda, Juan Antonio; Castells, Lluis; Buti, Maria; Lens, Sabela Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ledipasvir and Sofosbuvir for HCV Infection in Patients Coinfected with HBV. Issue 7 (October 2016) Authors: Gane, Edward J; Hyland, Robert H; An, Di; Svarovskaia, Evguenia S; Brainard, Diana; McHutchison, John G Journal: Antiviral therapy Issue: Volume 21:Issue 7(2016) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗